Refine your search

    Advanced filters

    Refine your search further by applying these filters.
    Location
      Status
      Sex
      Age

      Advanced filters

      25 trials found for Lung Neoplasm, Lung Carcinoma, Lung cancer

      Recruiting
      Not yet recruiting
      Recruiting
      NCT06487078
      Analysis of the Effectiveness and Safety of Lorlatinib in Untreated ALK-Positive NSCLC Patients in a French Real-World Context

      ALK+ Non-Small-Cell Lung Carcinoma

      Male or Female
      18+ years
      1study location(s)
      Recruiting
      NCT04557449
      Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors

      Liposarcoma, Prostate Cancer, Breast Neoplasms, Adenocarcinoma of Lung

      Male or Female
      18+ years
      38study location(s)
      Recruiting
      NCT05599412
      Post Marketing Surveillance(PMS) Study of Lorviqua in Korea

      Metastatic ALK+ Non Small Cell Lung Cancer

      Male or Female
      18+ years
      1study location(s)
      Jul 10, 2025 - Planned start date (Not yet recruiting)
      NCT07013474
      A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised

      COVID-19 Infection

      Male or Female
      18+ years
      12study location(s)
      Jun 30, 2025 - Planned start date (Not yet recruiting)
      NCT06678555
      A Study to Learn About Lorlatinib in Patients With Non-Small Cell Lung Cancer (NSCLC) Which Has Spread Out.

      Carcinoma, Non-Small-Cell Lung

      Male or Female
      18+ years

      Saved trials

      Saved trials

      You currently don’t have any saved trials. To save a trial, select the bookmark icon on the result listing.

      Recruiting
      Not yet recruiting

      Contact us

      For more information about participation in a Pfizer clinical trial, please email or call the Pfizer Clinical Trial Contact Center at 1-800-887-7002.